Breast cancer is the most common disease in the European Union, accounting for 13.3 per cent of all new cancer cases in 2020. Breast cancer is expected to affect 1 in every 11 women in the EU by the age of 74.
Women with breast cancer will be enrolled in a clinical trial to investigate the ability of behavioural and psychological therapy to minimise the cardiac damage caused by anti-cancer medications. The unique CARDIOCARE initiative is being led by a coalition of European partners, including the
New Delhi [India], August 2: Flawless Pharma Private Limited a research-based integrated pharmaceutical company involved in niche API manufacturing & marketing of pharmaceutical ingredient supplier for foremost formulators with services, including APIs, custom pharmaceutical services, ge
Bengaluru (Karnataka) [India], June 2: Dimple Parmar, Founder & CEO of ZenOnco.io, has been awarded the prestigious Cartier Women's Initiative Award 2023 for her significant contributions to the Indian cancer care ecosystem. Dimple Parmar started ZenOnco.io after losing her husband and I
A recent study suggested that spinal cord stimulation (SCS) may be effective in lowering chronic pain in persons receiving active therapy with a standard anti-cancer medicine, according to researchers at Johns Hopkins University School of Medicine.
New Delhi [India], April 19 (ANI/SRV): Aaquaries Global Industries Limited, Mumbai based top research-driven pharmaceutical company started in the year 2007 focusing on contract manufacturing APIs from Natural Extracts for Malaria Anti - Cancer & various other segments & a leading ex
Chemotherapy treatments produce strong side effects. A new agent that accumulates in the tumour tissue and is activated there by ultrasound waves does not have this problem.
New Delhi [India], March 6 (ANI/SRV): Aaquaries Global Industries Limited, a research-based integrated pharmaceutical company involved in niche API manufacturing & marketing of pharmaceutical ingredient supplier for foremost formulators with services, including APIs, custom pharmaceutica
Tumor cells typically alter their energy metabolism and increase glucose uptake to support their rapid division and spread. This limits glucose availability for immune cells and therefore dampens the body's anti-cancer immune response.
According to Sun Pharma, Palbociclib is approved by the US Food and Drugs Administration (FDA), European Medicines Agency (EMA) and Central Drugs Standard Control Organisation (CDSCO) in combination with hormonal therapies for patients with hormone receptor-positive, human epidermal growth f
A Ludwig Cancer Research study has revealed a single protein expressed at high levels by cancer cells across a broad range of malignancies that erects a multifaceted barrier to anti-cancer immune responses in mouse models of cancer and so shields tumours from immune detection and destruction